Magnetic Resonance Spectroscopy biomarkers predict patient outcome in subacute 
spinal cord injury

Wyss, P; Zweers, P; Brust, A; Funk, C; Berger, M; Henning, A

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Poster

Magnetic Resonance Spectroscopy biomarkers predict patient outcome in subacute spinal cord injury

MPS-Authors

/persons/resource/persons214569

Wyss, P
Research Group MR Spectroscopy and Ultra-High Field Methodology, Max Planck Institute for Biological Cybernetics, Max Planck Society;
Max Planck Institute for Biological Cybernetics, Max Planck Society;

/persons/resource/persons84402

Henning, A
Max Planck Institute for Biological Cybernetics, Max Planck Society;
Research Group MR Spectroscopy and Ultra-High Field Methodology, Max Planck Institute for Biological Cybernetics, Max Planck Society;

External Resource

https://www.ismrm.org/18/program_files/EP09.htm
(Abstract)

https://www.ismrm.org/18/Electronic_Posters.pdf
(Abstract)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Wyss, P., Zweers, P., Brust, A., Funk, C., Berger, M., & Henning, A. (2018). Magnetic Resonance Spectroscopy biomarkers predict patient outcome in subacute spinal cord injury. Poster presented at Joint Annual Meeting ISMRM-ESMRMB 2018, Paris, France.

Cite as: https://hdl.handle.net/21.11116/0000-0001-7DA4-A

Abstract

Spinal cord injury (SCI) is a very heterogeneous disease that makes it difficult to identify a single biomarker during rehabilitation therapy in order to predict the future patient status. In this study, we applied Magnetic Resonance Spectroscopy to examine specific metabolic markers in the pons 10 weeks after injury and correlated them with changes of the clinical status obtained twice during early rehabilitation.